Karen Sinclair and Sarah Cox of Griffith Hack review the Australian federal government’s budget measures for R&D, innovation, and medical technology funding
Despite being a market of only 26 million people, Australia possesses a world-class healthcare system and well regarded scientific community. This is most recently demonstrated through the participation of Australian scientists in the race to successfully manufacture a COVID-19 vaccine, and by the low infection death rates from the current pandemic in Australia.
